Zoetis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. 

CEO
Kristin C. Peck
CEOKristin C. Peck
Employees
13,800
Employees13,800
Headquarters
Parsippany, New Jersey
HeadquartersParsippany, New Jersey
Founded
1952
Founded1952
Employees
13,800
Employees13,800

ZTS Key Statistics

Market cap
63.87B
Market cap63.87B
Price-Earnings ratio
24.77
Price-Earnings ratio24.77
Dividend yield
1.34%
Dividend yield1.34%
Average volume
2.59M
Average volume2.59M
High today
$145.03
High today$145.03
Low today
$142.71
Low today$142.71
Open price
$143.94
Open price$143.94
Volume
2.46M
Volume2.46M
52 Week high
$183.81
52 Week high$183.81
52 Week low
$139.34
52 Week low$139.34

ZTS News

Nasdaq 1d
Ex-Dividend Reminder: Northwest Natural Holding, Cadre Holdings and Zoetis

Looking at the universe of stocks we cover at Dividend Channel, on 10/31/25, Northwest Natural Holding Co (Symbol: NWN), Cadre Holdings Inc (Symbol: CDRE), and...

Ex-Dividend Reminder: Northwest Natural Holding, Cadre Holdings and Zoetis
TipRanks 1d
Zoetis granted marketing authorization for Portela by European Commission

Zoetis (ZTS) announced that the European Commission has granted the company marketing authorization for Portela, making it the first monoclonal antibody therapy...

Simply Wall St 2d
Here's What We Like About Zoetis' Upcoming Dividend

Zoetis Inc. ( ) is about to trade ex-dividend in the next 2 days. The ex-dividend date is one business day before the record date, which is the cut-off date for...

Here's What We Like About Zoetis' Upcoming Dividend

Analyst ratings

76%

of 21 ratings
Buy
76.2%
Hold
23.8%
Sell
0%

More ZTS News

TipRanks 2d
Zoetis Appoints Stephanie Tilenius to Board of Directors

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Simply Wall St 5d
Zoetis: Evaluating Valuation After Health Canada Clears New Lenivia Osteoarthritis Therapy

Zoetis (ZTS) just received Health Canada approval for Lenivia, its new injection therapy for canine osteoarthritis pain. This development broadens Zoetis’ portf...

Zoetis: Evaluating Valuation After Health Canada Clears New Lenivia Osteoarthritis Therapy

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.